142 related articles for article (PubMed ID: 19837486)
1. [Bone scintigraphy and scintigraphy with (111)In-octreotide in the diagnosis of bone metastasis of bronchial carcinoid tumor].
Pérez Angel F; Sánchez Catalicio J; Mohamed Salem L; Castellón Sánchez MI; Navarro Fernández JL; Claver Valderas MA
Rev Esp Med Nucl; 2010; 29(1):38-9. PubMed ID: 19837486
[No Abstract] [Full Text] [Related]
2. Diagnosis of ectopic ACTH production from a bronchial carcinoid by imaging with octreotide scintigraphy.
Kristoffersson A; Olsson T; Björnebrink J; Hägg E
Eur J Surg; 1996 Jun; 162(6):515-8. PubMed ID: 8817232
[No Abstract] [Full Text] [Related]
3. [Bronchial carcinoid tumor and scintigraphy of somatostatin receptors: detection of bone metastasis].
Banzo J; Abós MD; Prats E; García F; Freile E; Razola P; Escalera T
Rev Esp Med Nucl; 2001 Oct; 20(6):431-8. PubMed ID: 11578577
[TBL] [Abstract][Full Text] [Related]
4. [Somatostatin receptor scintigraphy in pediatric bronchial carcinoid tumor].
Hervás Benito I; Bello Arques P; Loaiza JL; Vercher JL; Velasco RP; Rivas Sánchez A; Ruiz Llorca C; Martí Vidal JF; Mateo Navarro A
Rev Esp Med Nucl; 2010; 29(1):25-8. PubMed ID: 19819594
[TBL] [Abstract][Full Text] [Related]
5. In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin.
Fuster D; Navasa M; Pons F; Vidal-Sicart S; Mateos JJ; Lomeña F; Rodes J; Herranz R
Clin Nucl Med; 1999 Dec; 24(12):955-8. PubMed ID: 10595476
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease.
Zuetenhorst JM; Hoefnageli CA; Boot H; Valdés Olmos RA; Taal BG
Nucl Med Commun; 2002 Aug; 23(8):735-41. PubMed ID: 12124478
[TBL] [Abstract][Full Text] [Related]
7. [Bronchial carcinoid studied by spiral computed tomography with 3-dimensional reconstructions and virtual endoscopy. A case].
Aliberti C; Benetti S; Benea G
Radiol Med; 2000; 100(1-2):71-3. PubMed ID: 11109458
[No Abstract] [Full Text] [Related]
8. [Cushing's syndrome secondary to bronchial carcinoid tumor: contribution of gammagraphy with 111In-DTPA octreotide in the localization diagnosis].
Peña González E; Lampreave Márquez JL; León Atance P; Moreno Esteban B; Bittini Copano A; Folqué Gómez E
An Med Interna; 1999 Nov; 16(11):577-9. PubMed ID: 10637999
[TBL] [Abstract][Full Text] [Related]
9. Ectopic ACTH syndrome due to occult bronchial carcinoid.
Corsello SM; Fintini D; Lovicu RM; Paragliola RM; Rufini V; Simonetti G; Pontecorvi A
Clin Nucl Med; 2009 Jul; 34(7):459-61. PubMed ID: 19542957
[No Abstract] [Full Text] [Related]
10. [Thoracic SPECT using (111 In-DTPA-D-Phe1)-octreotide in bronchial carcinoid syndrome].
Banzo J; Sebastián A; Prats E; Freile E; García F; Costán J; Razola P; Tomás A; Cegoñino J; Abós MD
Rev Esp Med Nucl; 1998; 17(1):45-8. PubMed ID: 9609844
[TBL] [Abstract][Full Text] [Related]
11. Bronchopulmonary carcinoid tumor and related cervical vertebral metastasis with PET-positive and octreotide-negative scintigraphy.
Nguyen BD; Ram PC
Clin Nucl Med; 2006 Feb; 31(2):101-3. PubMed ID: 16424699
[No Abstract] [Full Text] [Related]
12. Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism.
Meijer WG; van der Veer E; Jager PL; van der Jagt EJ; Piers BA; Kema IP; de Vries EG; Willemse PH
J Nucl Med; 2003 Feb; 44(2):184-91. PubMed ID: 12571207
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I
J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
[TBL] [Abstract][Full Text] [Related]
14. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
15. Imaging of bronchial carcinoid tumors associated to Cushing syndrome with 111In-Octreoscan scintigraphy and immunoscintigraphy with anti-chromogranin monoclonal antibodies. Report of two cases.
Carretta A; Chiesa G; Magnani P; Songini C; Melloni G; Zannini P; Grossi A
J Cardiovasc Surg (Torino); 1997 Apr; 38(2):191-4. PubMed ID: 9201136
[TBL] [Abstract][Full Text] [Related]
16. [Bone scintigraphy and (111)In-octreotide in the diagnosis of bone metastasis of chemodectoma].
García JR; Minoves M; Bassa P; Fraile M
Rev Esp Med Nucl; 2006; 25(3):204-5. PubMed ID: 16762278
[No Abstract] [Full Text] [Related]
17. Metastatic renal carcinoid: case report and review of the literature.
Tal R; Lask DM; Livne PM
Urology; 2003 Apr; 61(4):838. PubMed ID: 12670585
[TBL] [Abstract][Full Text] [Related]
18. [Isotopic scan with somatostatin receptors in a case of recurrent carcinoid tumor. Relevance of tomographic detection].
Bernà Roqueta L; Martín Marimón JC; Martín Martínez J
Rev Esp Med Nucl; 2002 Apr; 21(2):123-4. PubMed ID: 11879622
[No Abstract] [Full Text] [Related]
19. Hilar bronchial carcinoid tumor: increased peritumoral vascular expression of somatostatin-2 receptor on an octreotide study?
Koh E; Patrikeos A; Steens R; Robins P
Clin Nucl Med; 2001 Oct; 26(10):870-1. PubMed ID: 11564931
[No Abstract] [Full Text] [Related]
20. Octreoscan in patients with bronchial carcinoid tumours.
Granberg D; Sundin A; Janson ET; Oberg K; Skogseid B; Westlin JE
Clin Endocrinol (Oxf); 2003 Dec; 59(6):793-9. PubMed ID: 14974924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
